Semaglutide Use Could Prevent Up to 2 Million MACE in 10 Years, Model Suggests
Nearly 2 million major cardiac events could be avoided through the use of semaglutide at its indicated dose among eligible patients, according to the researchers of a new modeling study published in Diabetes, Obesity and Metabolism.1 While the modeling showed that semaglutide at a dose of 2.4 mg could significantly reduce the incidence of and … Read more